Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease

IMPORTANCE: A reliable method of detecting Alzheimer disease (AD) in its prodromal state is needed for patient stratification in clinical trials or for personalizing existing or potential upcoming therapies. Current cerebrospinal fluid (CSF)– or imaging-based single biomarkers for AD offer reliable...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Neurol
Main Authors: Lehallier, Benoit, Essioux, Laurent, Gayan, Javier, Alexandridis, Roxana, Nikolcheva, Tania, Wyss-Coray, Tony, Britschgi, Markus
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5214993/
https://ncbi.nlm.nih.gov/pubmed/26659895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2015.3135
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados